Growth Metrics

Merck (MRK) Dividends payables (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.14%
Dec 31, 2025 4.80%
Sep 30, 2025 -0.54%
Jun 30, 2025 -1.16%
Mar 31, 2025 -0.34%
Dec 31, 2024 5.15%
Sep 30, 2024 0.05%
Jun 30, 2024 -1.34%
Mar 31, 2024 1.16%
Dec 31, 2023 5.75%
Sep 30, 2023 0.00%
Jun 30, 2023 -1.57%
Mar 31, 2023 1.22%
Dec 31, 2022 6.38%
Sep 30, 2022 0.17%
Jun 30, 2022 -0.17%
Mar 31, 2022 0.17%
Dec 31, 2021 6.51%
Sep 30, 2021 -0.12%
Jun 30, 2021 -0.78%
Mar 31, 2021 0.06%
Dec 31, 2020 6.83%
Sep 30, 2020 0.19%
Jun 30, 2020 -1.32%
Mar 31, 2020 -0.13%
Dec 31, 2019 10.67%
Sep 30, 2019 -0.35%
Jun 30, 2019 -1.57%
Mar 31, 2019 0.27%
Dec 31, 2018 11.81%
Sep 30, 2018 -0.38%
Jun 30, 2018 -0.61%
Mar 31, 2018 -0.23%
Dec 31, 2017 1.38%
Sep 30, 2017 0.08%
Jun 30, 2017 -0.99%
Mar 31, 2017 -0.15%
Dec 31, 2016 1.86%
Sep 30, 2016 0.00%
Jun 30, 2016 -1.15%
Mar 31, 2016 -0.15%
Dec 31, 2015 1.63%
Sep 30, 2015 -0.54%
Jun 30, 2015 -0.84%
Mar 31, 2015 -0.15%
Dec 31, 2014 1.55%
Sep 30, 2014 -1.15%
Jun 30, 2014 -1.81%
Mar 31, 2014 0.45%
Dec 31, 2013 2.48%
Sep 30, 2013 0.23%
Jun 30, 2012 2.11%
Mar 31, 2012 0.00%
Dec 31, 2011 9.86%
Sep 30, 2011 -0.85%
Jun 30, 2011 -0.08%
Mar 31, 2011 0.09%
Dec 31, 2010 0.03%
Sep 30, 2010 -0.53%
Jun 30, 2010 -0.66%
Mar 31, 2010 0.07%